A number of other equities analysts also recently commented on KKR. Credit Suisse Group downgraded shares of KKR & Co Inc from an “outperform” rating to a “neutral” rating and set a $29.00 target price on the stock. in a research note on Tuesday, May 21st. Citigroup set a $34.00 target price on shares of KKR & Co Inc and gave the company a “buy” rating in a research note on Friday, July 26th. Finally, Barclays initiated coverage on shares of KKR & Co Inc in a research note on Monday, August 5th. They issued an “equal weight” rating and a $29.00 target price on the stock. One research analyst has rated the stock with a sell rating, seven have issued a hold rating and five have issued a buy rating to the company. The company presently has an average rating of “Hold” and an average price target of $28.70.
Shares of KKR stock traded down $0.02 during mid-day trading on Thursday, reaching $25.17. The company’s stock had a trading volume of 1,560,951 shares, compared to its average volume of 3,260,689. The firm’s 50 day moving average is $25.72. KKR & Co Inc has a 12-month low of $18.30 and a 12-month high of $28.73. The company has a debt-to-equity ratio of 0.92, a current ratio of 1.09 and a quick ratio of 1.00. The stock has a market cap of $13.35 billion, a price-to-earnings ratio of 13.04, a PEG ratio of 6.96 and a beta of 1.65.
In related news, General Counsel David Sorkin sold 100,000 shares of KKR & Co Inc stock in a transaction on Thursday, August 1st. The shares were sold at an average price of $26.19, for a total transaction of $2,619,000.00. Following the sale, the general counsel now owns 73,528 shares of the company’s stock, valued at approximately $1,925,698.32. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link. Also, major shareholder Genetic Disorder L.P. Kkr purchased 2,647,100 shares of the company’s stock in a transaction that occurred on Monday, July 1st. The shares were purchased at an average cost of $17.00 per share, for a total transaction of $45,000,700.00. The disclosure for this purchase can be found here. Insiders own 39.34% of the company’s stock.
A number of institutional investors have recently added to or reduced their stakes in KKR. First Manhattan Co. purchased a new stake in KKR & Co Inc during the 1st quarter worth $132,421,000. Diamond Hill Capital Management Inc. acquired a new position in KKR & Co Inc during the 1st quarter worth $113,172,000. BlackRock Inc. grew its holdings in KKR & Co Inc by 35.9% during the 1st quarter. BlackRock Inc. now owns 14,471,966 shares of the asset manager’s stock worth $339,948,000 after acquiring an additional 3,823,413 shares in the last quarter. Iridian Asset Management LLC CT grew its holdings in KKR & Co Inc by 3,806.8% during the 1st quarter. Iridian Asset Management LLC CT now owns 3,817,419 shares of the asset manager’s stock worth $89,671,000 after acquiring an additional 3,719,706 shares in the last quarter. Finally, Sumitomo Mitsui Trust Holdings Inc. acquired a new position in KKR & Co Inc during the 1st quarter worth $44,185,000. 76.72% of the stock is currently owned by hedge funds and other institutional investors.
About KKR & Co Inc
KKR & Co L.P. is a private equity and real estate investment firm specializing in direct and fund of fund investments. It specializes in acquisitions, leveraged buyouts, management buyouts, credit special situations, growth equity, mature, mezzanine, distressed, turnaround, lower middle market and middle market investments.
Recommended Story: How does quantitative easing work?
To view ValuEngine’s full report, visit ValuEngine’s official website.
Receive News & Ratings for KKR & Co Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for KKR & Co Inc and related companies with MarketBeat.com's FREE daily email newsletter.